We present a 3-year-old girl with an asymptomatic patent ductus arteriosus (PDA) awaiting an elective transcatheter device closure. She presented with a 2-week history of high-grade fever (40°C).

usa.net Background: The design of devices currently used for closure of persistent ductus arteriosus (PDA) with high pulmonary artery pressure is not ideal and there is a risk of embolisation into the ...

OBJECTIVE To evaluate the in vivo biocompatibility of three different devices following interventional closure of a patent ductus arteriosus (PDA) in an animal model. MATERIALS AND METHODS A medical ...

The challenge here was to consider for closure of the hole at such a low weight with associated features of systemic inflammation. However, in this case, we chose to opt for PDA device closure ...

Following its introduction into clinical practice, the Amplatzer duct occluder (ADO) has achieved a definite place in the armamentarium of the interventional cardiologist for the closure of moderate ...

The AMPLATZER Piccolo™ Occluder is a percutaneous, transcatheter occlusion device intended for the nonsurgical closure of a patent ductus arteriosus (PDA). Pregnancy — Minimize radiation exposure to ...

PDA most often affects babies who are born prematurely ... Larger holes may be closed with a device inserted with catheterization. Device closure of patent foramen ovale (PFO) The foramen ovale is an ...

“The challenge here was to consider closure of the hole at such a low weight with associated features of systemic inflammation. We chose to opt for PDA device closure which helped close the hole ...

Percutaneous closure of patent ductus arteriosus using a duct occluder has become standard of care in its management especially in children more than 6 months of age, weighing more than 6 kg but ...